Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep

Veterinary Journal

Volumn 180, Issue 3, 2009, Pages 343-347

  Cárceles, Carlos M ^a   Escudero, Elisa ^a   Fernández Varón, Emilio ^a   Marín, Pedro ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Bioavailability; Fluoroquinolones; Moxifloxacin; Pharmacokinetics; Sheep

Indexed keywords

MOXIFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG INDICATION; FEMALE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; SHEEP; SINGLE DRUG DOSE; STEADY STATE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; AZA COMPOUNDS; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; QUINOLINES; SHEEP;

OVIS ARIES;

EID: 61849163338     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.11.025     Document Type: Article

References (36)

1. Aliabadi F., and Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62 (2001) 1979-1989
2. Aliabadi F., Landoni M.F., and Lees P. Pharmacokinetics (PK), Pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 47 (2003) 626-635
3. Bermingham E.C., and Papich M.G. Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. American Journal of Veterinary Research 63 (2002) 1012-1017
4. Brogden K.A., Lehmkuhl H.D., and Cutlip R.C. Pasteurella haemolytica complicated respiratory infections in sheep and goats. Veterinary Research 29 (1998) 233-254
5. Brown S.A. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 1-14
6. Cárceles C.M., Villamayor L., Escudero E., Marín P., and Fernández-Varón E. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. The Veterinary Journal 173 (2007) 452-455
7. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26 (1998) 1-10
8. Drlica K., and Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61 (1997) 377-392
9. Fernández-Varón E., Bovaira M.J., Espuny A., Escudero E., Vancraeynest D., and Cárceles C.M. Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 343-348
10. Fernández-Varón E., Villamayor L., Escudero E., Espuny A., and Cárceles C.M. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. The Veterinary Journal 172 (2006) 302-307
11. Fernández-Varón E., Ayala I., Marín P., Carrión A., Martos N., Escudero E., and Cárceles C.M. Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration. Equine Veterinary Journal 38 (2006) 342-346
12. Fernández-Varón E., Marín P., Espuny A., Villamayor L., Escudero E., and Cárceles C.M. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%). Journal of Clinical Pharmacy and Therapeutics 31 (2006) 641-643
13. Fernández-Varón E., Marín P., Escudero E., Vancraeynest D., and Cárceles C.M. Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits. Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 18-24
14. Gardner S.Y., Davis J.L., Jones S.L., Lafevers D.H., Hoskins M.S., Mcarver E.M., and Papich M.G. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 57-60
15. Gibaldi M., and Perrier P. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York
16. Haddad N.S., Pedersoli W.M., Ravis W.R., Fazeli M.H., and Carson R.L. Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. American Journal of Veterinary Research 46 (1985) 2004-2007
17. Haritova A., Lashev L., and Pashov D. Pharmacokinetics of enrofloxacin in lactating sheep. Research in Veterinary Science 74 (2003) 241-245
18. Hore D.E. A review of respiratory agents associated with disease of sheep, cattle and pigs in Australia and overseas. Australian Veterinary Journal 52 (1976) 502-509
19. Kalaiselvi L., Sriranjani D., Sriram P., and Mathuram L.N. Pharmacokinetics of ofloxacin in broiler chicken. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 185-189
20. Lees P., and Shojaee Aliabadi F. Rational dosing of antimicrobial drugs: animals versus human. International Journal of Antimicrobial Agents 19 (2002) 269-284
21. Lode H., Borner K., and Koeppe P. Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease 27 (1998) 33-39
22. Marín P., Fernández-Varón E., Escudero E., and Cárceles C.M. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep. Research in Veterinary Science 83 (2007) 234-238
23. Marín P., Escudero E., Férnandez-Varón E., and Cárceles C.M. Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Journal of Dairy Science 90 (2007) 4219-4225
24. Marín P., Escudero E., Férnandez-Varón E., and Cárceles C.M. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 74-79
25. McKellar Q., Gibson I., and McCormack R. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition 19 (1998) 123-129
26. Patel T., Pearl J., Williams J., Haverstock D., and Church D. Efficacy and safety of 10-day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Respiratory Medicine 94 (2000) 97-105
27. Power J. Statistical analysis of pharmacokinetics data. Journal of Veterinary Pharmacology and Therapeutics 13 (1990) 113-120
28. Shojaee Aliabadi F., and Lees P. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. International Journal of Antimicrobial Agents 14 (2000) 307-313
29. Shumaker R.C. PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews 17 (1986) 331-348
30. Siefert H.M., Kohlsdorfer C., Steinke W., and Witt A. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy 43 (1999) 61-67
31. Toutain P.L., and Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 467-477
32. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58 (1999) 29-36
33. Walker R.D. Fluoroquinolones. In: Prescott J.F., Baggot J.D., and Walker R.D. (Eds). Antimicrobial Therapy in Veterinary Medicine. third ed. (2000), Iowa State University Press, Ames, USA 315-338
34. Wolfson J.S., and Hooper D.C. Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews 2 (1989) 378-424
35. Yamaoka K., Tamigawara Y., and Uno J. A pharmacokinetic analysis program (MULTI) for microcomputers. Journal of Pharmacobio-Dynamics 4 (1981) 879-885
36. Yamaoka K., Nakagawa T., and Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal Pharmacokinetics Biopharmaceutics 6 (1978) 165-175